Cancer personality: Current view and implications for future research

Česká verzia

Authors: M. Blatný ¹; Z. Adam ²
Authors place of work: Psychologický ústav Akademie věd ČR, v. v. i., Brno, ředitel prof. PhDr. Marek Blatný, CSc. ¹; Interní hematoonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jiří Vorlíček, CSc. ²
Published in the journal: Vnitř Lék 2008; 54(6): 638-645
Category: Reviews

Summary

The paper provides an outline of the present state of knowledge of the ’C-type’ or cancer-prone personality. Links between personality and cancer have been studied approximately since the mid 1960’s. Opinions on the role of personality dispositions and other psychosocial factors in the development of cancer have been changing over the last 50 years. There are basically two periods marking the evolution of thought on the subject. While in the early 1990’s, results of research were interpreted in favour of the existence of the C-type personality, in spite of a lack of consistency (and often contradictory findings), currently they are interpreted in disfavour of the C-type personality due to continuing uncertainty. The current view is primarily based on the fact that specific links between cancer and certain personality traits have not been confirmed. In conclusion, the authors reflect over what could have been done better from the methodological point of view in studies carried out so far, and suggest suitable study design options.

Key words:
cancer-prone personality – cancer – risk – methodology

Zdroje

1. Straub J, Adam Z, Gregora E et al. Mnohočetný myelom - projekt časné diagnostiky „CRAB“. Medical Tribune 2007; 3: 4-5.

2. Jedlička F, Elbl L, Vášová I et al. Únavový syndrom u onkologického pacienta: možnosti diagnostiky a léčby. Vnitř Lék 2007; 53: 979-985.

3. Gorbunov EA, Wechsler J. Prognóza a prognostické faktory v onkologii a onkochirurgii. Vnitř Lék 2004; 50: 61-65.

4. Adam Z, Pour L, Svobodník A et al. Kvalita života a tolerance udržovací léčby u pacientů s mnohočetným myelomem. Vnitř Lék 2002; 48: 216-229.

5. Munzarová M. Etické aspekty léčby pokročilých stavů u onkologicky nemocných. Vnitř Lék 2002; 48: 611-613.

6. Munzarová M. Psychologie a etika péče o onkologicky nemocné. Vnitř Lék 2001; 47: 576-578.

7. Kottnauerová S, Kožená L, Sovinová H. Screening psychosociálních faktorů a jeho vyhodnocování s použitím programu pro PC. Jednotlivé faktory a jejich možná rizika. Pacient.cz 2006 [online]. Dostupné z https://www.zdravcentra.cz/cps/rde/xchg/zc/xsl/3141_1367.html.

8. Contrada RJ, Leventhal H, O’Leary A. Personality and health. In: Pervin LA. Handbook of Personality: Theory and Research. New York/London: The Guilford Press 1990: 638-669.

9. Eysenck HJ. Cancer, personality and stress: Prediction and prevention. Advances in Behaviour Research & Therapy 1994; 16: 167-215.

10. Hagnell O. The premorbid personality of persons who develop cancer in a total population investigated in 1947 and 1957. Ann NY Acad Sci 1966; 125: 846-855.

11. Kissen DM, Eysenck HJ. Personality in male lung cancer patients. J Psychosom Res 1962; 6: 123-127.

12. Temoshok L, Dreher H. The “Type-C connection” and Reply to a Review. New York Times Book Review 1992: 26.

13. Shekelle RB, Raynor WJ, Ostfield AM et al. Psychological depression and 17-year risk of death from cancer. Psychosom Med 1981; 43: 117-125.

14. Jansen MA, Muenz LR. A retrospective study of personality variables associated with fibrocystic disease and breast cancer. J Psychosom Res 1984; 28: 35-42.

15. Pettingale KV, Burgess C, Greer S. Psychological response to cancer diagnosis: I. Correlations with prognostic variables. J Psychosom Res 1988; 32: 255-261.

16. Niemi T, Jaaskelainen J. Cancer morbidity in depressive persons. J of Psychosom Res 1978; 22: 117-120.

17. Derogatis LR, Abeloff MD, Melisaratos N. Psychological coping mechanisms and survival time in metastatic breast cancer. J Am Med Assoc 1979; 242: 1504-1508.

18. Grossarth-Maticek R, Kanazir DT, Schmidt P et al. Psychosomatic factors in the process of carcinogenesis. Psychother Psychosom 1982; 38: 284-302.

19. Shaffer JW, Duzsynski KR, Thomas CB. Family attitudes in youth as a possible precursor of cancer among physicians: A search for explanatory mechanisms. J Behav Med 1982; 5: 143-163.

20. Horne RL, Picard RS. Psychosocial risk factors for lung cancer. Psychosom Med 1979; 41: 503-514.

21. Levy SM, Herbeman RB, Maluish AM et al. Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychol 1985; 4: 99-113.

22. Spiegel D, Bloom JR, Kraemer HC et al. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet 1989; ii: 888-891.

23. Kissen DM, Brown RIF, Kissen M. A further report on personality and psychosocial factors in lung cancer. Ann NY Acad Sci 1969; 164: 535-545.

24. Morris T, Greer S, Pettingale KW et al. Patterns of expressing anger and their psychological correlates in women with breast cancer. J Psychosom Res 1981; 25: 111-117.

25. Stavraky KM. Psychological factors in the outcomes of human cancer. J Psychosom Res 1968; 12: 251-259.

26. Wirsching M, Stierlin H, Hoffman F et al. Psychological indicators of breast cancer patients before biopsy. J Psychosom Res 1979; 26: 1-10.

27. Temoshok L, Heller BW, Sagebiel RW et al. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma. J of Psychosom Res 1985; 29: 139-154.

28. Rogentine GN, Van Kammen DP, Fox BH et al. Psychological factors in the prognosis of malignant melanoma: A prospective study. Psychosom Med 1979; 41: 647-655.

29. Greer S, Morris T, Pettingale KW. Psychological response to breast cancer. Effect on outcome. Lancet 1979; ii: 785-787.

30. Kalvodová L. Bojový duch jako psychologický fenomén onkologických pacientů. Onkologická péče 2006; 10: 21-24.

31. Jensen MR. Psychobiological factors predicting the course of breast cancer. J Pers 1987; 55: 317-342.

32. Hochschild AR. The managed heart: Commercialization and human feeling. Berkeley: University of California Press 1983.

33. Greer S, Morris T. Psychological attributes of women who develop breast cancer: A controlled study. J Psychosom Res 1975; 19: 147-153.

34. McKenna MC, Zevon MA, Corn B et al. Psychosocial factors and the development of breast cancer: A meta-analysis. Health Psychol 1999; 18: 520-531.

35. Sampson W. Controversies in cancer and the mind: Effects of psychosocial support. Semin Oncol 2002; 29: 595-600.

36. Schwarz R. Die “Krebspersonlichkeit” - Mythen Und Forschungsresultate. Psychoneuros 2004; 30: 201-209.

37. Aro AR, De Koning HJ, Schreck M et al. Psychological risk factors of incidence of breast cancer: A prospective cohort study in Finland. Psychol Med 2005; 35: 1515-1521.

38. Nakaya N, Tsubono Y, Nishino Y et al. Personality and cancer survival: the Miyagi cohort study. Brit J Cancer 2005; 92: 2089-2094.

39. Tsubono Y, Nakaya N, Tsuji I. Re: Personality and the risk of cancer - Response. J Natl Cancer I 2003, 95: 1638.

40. Hansen PE, Floderus B, Frederiksen K et al. Personality traits, health behavior, and risk for cancer. Cancer 2005; 103: 1082-1091.

41. Sturmer T, Hasselbach P, Amelang M. Personality, lifestyle, and risk of cardiovascular disease and cancer: follow-up of population based cohort. Br Med J 2006; 332: 1359-1365.

42. Denollet J. Personality and risk of cancer in men with coronary heart disease. Psychol Med 1998; 28: 991-995.

43. Kroenke CH, Bennett GG, Fuchs C et al. Depressive symptoms and prospective incidence of colorectal cancer in women. Am J Epidemiol 2005; 162: 839-848.

44. Fox BH. Premorbid psychological factors as related to cancer incidence. J Behav Med 1978; 1: 45-133.

45. Cloninger RC, Przybeck TR, Svrakic DM et al. The Temperament and Character Inventory (TCI): A Guide to Its Development and Use. Washington: Center for Psychobiology of Personality, Washington University 1994.

46. Costa PT, McCrae RR. NEO PI-R. Revised NEO Personality Inventory (NEO PI-R) and NEO Five-Factor Inventory (NEO-FFI). Odessa: Psychological Assessment Resources 1992.